Home » Knowledge Center » Safety Assessment Service Overview
An advertisement for Pharmaron's Safety Assessment services, featuring a brochure cover and a "Download Below" button. Highlighting preclinical ADME studies, the background showcases geometric patterns with the company logo prominently in the top left and bottom right corners alongside the text "Pharmaron.

Safety Assessment Service Overview

Unlock the path to regulatory success with Pharmaron’s comprehensive safety assessment services, designed to address the unique needs of every drug candidate. With over 2,000 safety studies conducted and extensive expertise across small molecules, biologics, and advanced modalities like cell and gene therapies, Pharmaron is your trusted partner for preclinical and IND-enabling studies.

Key takeaways from this brochure include:

  • End-to-End Capabilities: From acute to chronic toxicity studies, developmental and reproductive toxicology, and genotoxicity to environmental risk assessments, our offerings cover every aspect of safety evaluation.
  • Specialized Expertise: Our services include safety assessment for ocular and dermal drugs, medical devices, and emerging therapeutic areas, supported by advanced imaging and pathology techniques.
  • Regulatory Excellence: Accredited by global regulatory agencies, including FDA, EMA, and MHRA, we ensure rigorous compliance and high-quality data to maximize approval success.

With AAALAC-accredited facilities and integrated services from discovery to post-marketing, Pharmaron simplifies the safety assessment process, providing seamless support at every stage. Download the brochure today and learn how our tailored solutions can help you achieve your development goals.